Lexington startup raises $55M to advance Pfizer's shelved work
June 03, 2020 at 05:15 AM EDT
NodThera hopes to create treatments for chronic conditions like NASH, inflammatory bowel disease and even neurodegenerative diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|